SANJAY MATHEW to Clinical Trials as Topic
This is a "connection" page, showing publications SANJAY MATHEW has written about Clinical Trials as Topic.
Connection Strength
0.287
-
Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry. 2015 Mar; 76(3):247-52.
Score: 0.088
-
Does ketamine have anti-suicidal properties? Current status and future directions. CNS Drugs. 2015 Mar; 29(3):181-8.
Score: 0.088
-
Treatment-resistant depression: recent developments and future directions. Depress Anxiety. 2008; 25(12):989-92.
Score: 0.053
-
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019 06; 44(7):1233-1238.
Score: 0.029
-
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nat Rev Drug Discov. 2018 12 28; 18(1):82-84.
Score: 0.029